Answers are grounded in this paper and cite their sources.
The catalytic promiscuity of cytochrome P450 CYP725A4 severely impedes paclitaxel biosynthesis, as it generates taxadien-5α-ol (T-5α-ol) alongside numerous by-products. Despite diverse proposed mechanisms and the reported role of facilitator of taxane oxidation (FoTO1) in promoting T-5α-ol formation, conclusive evidence elucidating the catalytic promiscuity of CYP725A4 remains elusive. Here, we report a substrate mimic strategy using taxadien-2-one (taxadienone), which is selectively epoxidized by CYP725A4 at the C4=C5 double bond, suggesting epoxidation as its major catalytic pathway. This notion was then confirmed by the successful identification of the long-observed yet structurally uncharacterized major taxadiene oxidation product as 4(5)α-epoxy-taxadiene, which can spontaneously rearrange in solution. Furthermore, the minor T-5α-ol produced by CYP725A4 arises from a concurrent hydroxylation pathway rather than from epoxidation, and efficient isomerization of 4(5)α-epoxy-taxadiene to T-5α-ol by FoTO1 is required to achieve improved product selectivity. Employing the promiscuity-free taxadienone as a probe substrate eliminated analytical complications and led to variant M3, which shows markedly enhanced catalytic activity through optimized heme-binding and enhanced FG loop flexibility. Finally, co-expressing the plant-derived FoTO1 with the CYP725A4 variant M3 in engineered Escherichia coli increased T-5α-ol production to 109.1 mg/L in a 5 L bioreactor. Collectively, this strategy provides crucial insights into CYP725A4 catalytic promiscuity and enables more efficient directed evolution, thereby facilitating downstream paclitaxel pathway optimization.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: